A Systems Biology Approach to Advancing Adverse Outcome Pathways for Risk Assessment

Social pressure to minimize the use of animal testing, the ever-increasing concern on animal welfare, and the need for more human-relevant and more predictive toxicity tests are some of the drivers for new approaches to chemical screening. This book focuses on The Adverse Outcome Pathway, an analyti...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Garcia-Reyero, Natàlia (Editor, http://id.loc.gov/vocabulary/relators/edt), Murphy, Cheryl A. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2018.
Edition:1st ed. 2018.
Subjects:
Online Access:Full Text via HEAL-Link
LEADER 04150nam a2200469 4500
001 978-3-319-66084-4
003 DE-He213
005 20191220131231.0
007 cr nn 008mamaa
008 180224s2018 gw | s |||| 0|eng d
020 |a 9783319660844  |9 978-3-319-66084-4 
024 7 |a 10.1007/978-3-319-66084-4  |2 doi 
040 |d GrThAP 
050 4 |a QH301-705 
072 7 |a PSA  |2 bicssc 
072 7 |a SCI086000  |2 bisacsh 
072 7 |a PSA  |2 thema 
082 0 4 |a 570  |2 23 
245 1 2 |a A Systems Biology Approach to Advancing Adverse Outcome Pathways for Risk Assessment  |h [electronic resource] /  |c edited by Natàlia Garcia-Reyero, Cheryl A. Murphy. 
250 |a 1st ed. 2018. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2018. 
300 |a XIV, 422 p. 77 illus., 64 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a 1. Introduction -- Part I: Biology -- 2. "Non-model" species for eco and human health risk assessment -- 3.The fish embryo as a model  for eco-toxicology and other potential models -- 4.Invertebrates/Plants -- 5.Behavioral/Neurobehavioral linkages to AOPs -- 6. Species extrapolation - common pathways etc -- 7.  Life History Evolution, incorporating evolutionary processes into AOPs to extrapolate -- Part II: Incorporating Biology into AOPs -- 8.Use of HTS assays to infer MIEs -- 9. AOP development: how to infer and define KER -- 10. The development of quantitative AOPs -- Part IV: Incorporating Modeling into AOPs.-11.Computational approaches (network science, etc) in AOPs: linking molecular datasets -- 12.Computational approaches : Dynamic Energy Budgets -- 13.  Modeling approaches in AOPs: extrapolation from individual to population -- 14.  Modeling approaches that augment AOPs: GUTS, QSAR, TKTD PBTKTD -- 15.  Exposure science and other stressors? How to incorporate -- 16.  AOP as an organizing framework and implications for biological science-AOP evolution -- 17. Use and acceptance of AOPs for regulatory applications, use of AOPs in human risk assessment, and legislation. . 
520 |a Social pressure to minimize the use of animal testing, the ever-increasing concern on animal welfare, and the need for more human-relevant and more predictive toxicity tests are some of the drivers for new approaches to chemical screening. This book focuses on The Adverse Outcome Pathway, an analytical construct that describes a sequential chain of causally linked events at different levels of biological organization that lead to an adverse health or ecotoxicological effect. While past efforts have focused on toxicological pathway-based vision for human and ecological health assessment relying on in vitro systems and predictive models, The Adverse Outcome Pathway framework provides a simplified and structured way to organize toxicological information. Within the book, a systems biology approach supplies the tools to infer, link, and quantify the molecular initiating events and the key events and key event relationships leading to adverse outcomes. The advancement of these tools is crucial for the successful implementation of AOPs for regulatory purposes. 
650 0 |a Systems biology. 
650 0 |a Pharmacology. 
650 1 4 |a Systems Biology.  |0 http://scigraph.springernature.com/things/product-market-codes/L15010 
650 2 4 |a Pharmacology/Toxicology.  |0 http://scigraph.springernature.com/things/product-market-codes/B21007 
700 1 |a Garcia-Reyero, Natàlia.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Murphy, Cheryl A.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319660820 
776 0 8 |i Printed edition:  |z 9783319660837 
776 0 8 |i Printed edition:  |z 9783030097585 
856 4 0 |u https://doi.org/10.1007/978-3-319-66084-4  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)